326 results on '"Giuntoli, Robert L."'
Search Results
2. Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure
3. Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study
4. Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma
5. Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients with Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes
6. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database
7. Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma
8. Is there a benefit of performing an omentectomy for clinical stage I high-grade endometrial carcinoma?
9. Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma
10. An increase in multi-site practices: The shifting paradigm for gynecologic cancer care delivery
11. Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion
12. Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer
13. Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology
14. Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy
15. Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis
16. Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary
17. Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinoma
18. Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base
19. Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation
20. Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma
21. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
22. Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma
23. Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery
24. Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes
25. Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis
26. Utilization and outcomes of sentinel lymph node biopsy in patients with early stage vulvar cancer
27. Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium
28. Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment
29. Supplemental Figure 2. from VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells
30. Supplemental Figure 1. from VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells
31. Data from Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer
32. Supplementary Figure Legend from Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer
33. Supplementary Figure 1 from Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer
34. Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma
35. Non-surgical management of ovarian cancer: Prevalence and implications
36. Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis
37. Geographic access to gynecologic cancer care in the United States
38. Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database
39. A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer
40. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor
41. Survival implications of time to surgical treatment of endometrial cancers
42. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
43. Comparison of candidate serologic markers for type I and type II ovarian cancer
44. Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced müllerian cancer: a pilot study
45. Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer
46. Intraperitoneal Chemotherapy for Stage III Ovarian Cancer Using the Gynecologic Oncology Group Protocol 172 Intraperitoneal Regimen: Effect of Supportive Care Using Aprepitant and Pegfilgrastim on Treatment Completion Rate
47. Analysis of Contemporary Trends in Access to High-Volume Ovarian Cancer Surgical Care
48. Surgical Management of Mesenteric Lymph Node Metastasis in Patients Undergoing Rectosigmoid Colectomy for Locally Advanced Ovarian Carcinoma
49. Importance and Timing of End-of-Life Care Discussions Among Gynecologic Oncology Patients
50. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.